Skip to content

Effectiveness of Ginseng on the Symptoms of depression and anxiety in Drug users

Comparing the effectiveness of ginseng on the symptoms of depression and anxiety in drug users

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240310061238N1
Enrollment
34
Registered
2024-04-10
Start date
2024-07-05
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Anxiety. Condition 2: Anxiety. Anxiety disorder, unspecified Unspecified mood [affective] disorder

Interventions

Intervention 1: Intervention group: Patients receive ginseng capsules (100 mg) . The intervention group received two ginseng capsules (100 mg) daily for four weeks. Intervention 2: Patients receive pl

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Drug users who are undergoing maintenance treatment with methadone and buprenorphine in the age range of 18 to 60 years will be included in the study. Drug-dependent patients for at least one year using fixed-dose drugs at least in the last month

Exclusion criteria

Exclusion criteria: Pregnant or lactating mothers Patients with other psychological problems (bipolar-schizophrenia-dementia or mental retardation) Concomitant serious medical diseases

Design outcomes

Primary

MeasureTime frame
Anxious mood score with Hamilton questionnaire criteria. Timepoint: Examining the anxiety score with the Hamilton questionnaire, at the beginning of the study (before the start of the intervention), and 14 and 28 days after receiving ginseng. Method of measurement: Hamilton anxiety and depression questionnaire.;Depressed mood score with Hamilton questionnaire criteria. Timepoint: Examining the depression score with the Hamilton questionnaire, at the beginning of the study (before the start of the intervention), and 14 and 28 days after receiving ginseng. Method of measurement: Hamilton anxiety and depression questionnaire.

Secondary

MeasureTime frame
Sleep disorder score with Hamilton questionnaire criteria. Timepoint: Examining the sleep disorder score with the Hamilton questionnaire, at the beginning of the study (before the start of the intervention), and 14 and 28 days after receiving ginseng. Method of measurement: Hamilton anxiety and depression questionnaire.;Diminished ability to concentrate score with Hamilton questionnaire criteria. Timepoint: Examining the difficulty in concentration score with the Hamilton questionnaire, at the beginning of the study (before the start of the intervention), and 14 and 28 days after receiving ginseng. Method of measurement: Hamilton anxiety and depression questionnaire.;General physical condition score with Hamilton questionnaire criteria. Timepoint: Examining the score of general physical symptoms with the Hamilton questionnaire, at the beginning of the study (before the start of the intervention), and 14 and 28 days after receiving ginseng. Method of measurement: Hamilton anxiety and depression questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyede Fateme Mesbahi

Ahvaz University of Medical Sciences

fatememesbahi@yahoo.com+9861330383374

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026